Literature DB >> 27358310

Schnitzler Syndrome Without a Monoclonal Gammopathy: A Case Report.

Michelle Urbanski1, Karen Holfeld2, Ardyth Milne3, Mariam Abbas4.   

Abstract

BACKGROUND: Schnitzler syndrome (SS) is a rare autoinflammatory disorder characterized by a recurrent urticarial rash and a monoclonal immunoglobulin M gammopathy, as well as 2 of the following minor criteria: recurrent fever (>38°C), objective signs of abnormal bone remodeling, elevated C-reactive protein level or leukocytosis, and a neutrophilic infiltrate on skin biopsy. Alternatively, a monoclonal immunoglobulin G gammopathy may be present along with 3 minor criteria for diagnosis.
OBJECTIVE: To report a rare case of SS without monoclonal gammopathy and inform physicians of this possible clinical presentation so that treatment is not delayed.
METHODS: We report a case of a 62-year-old white man with a clinical diagnosis of SS without monoclonal gammopathy. He presented with chronic urticaria unresponsive to conventional therapy. RESULTS AND
CONCLUSIONS: To our knowledge, there have only been 3 case reports of SS in the absence of monoclonal gammopathy documented in the literature. SS should be considered based on clinical presentation, even in the absence of monoclonal gammopathy, to facilitate appropriate management.
© The Author(s) 2016.

Entities:  

Keywords:  Schnitzler syndrome; autoinflammatory

Mesh:

Substances:

Year:  2016        PMID: 27358310     DOI: 10.1177/1203475416657999

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  2 in total

Review 1.  Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review.

Authors:  Riccardo Bixio; Maurizio Rossini; Alessandro Giollo
Journal:  Clin Rheumatol       Date:  2020-11-11       Impact factor: 2.980

2.  A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra.

Authors:  Min Joo Ahn; Ji Eun Yu; Jiung Jeong; Da Woon Sim; Young Il Koh
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.